Meet Our Leadership TeamThe Center for Regulatory Strategies |
The Center for Regulatory Strategies delivers critical insights from a powerful team of former regulators, industry specialists, and trusted business advisers. The members of our leadership team have deep knowledge of how regulations affect business strategy and operations in heavily regulated industry sectors.
Meet Our Leadership Team
 |
Kevin is a partner with Deloitte, the leader of the Governance, Regulatory & Risk Strategies practice, and a member of the Executive Committee of Deloitte. He focuses on providing regulatory compliance, operational, and technology consulting services and advice to organizations in the investment management industry, including investment management firms, mutual funds, transfer agents, banks, broker-dealers, and insurance companies. Read more. |
 |
Deborah Bailey is a managing director in Deloitte & Touche LLP’s Governance, Regulatory & Risk Strategies practice, who has more than 35 years experience in navigating and directing a variety of supervisory programs at large federal regulatory agencies. Read more. |
 |
Marc Greathouse is a partner in the Advisory practice of Deloitte & Touche LLP. He has more than 15 years of experience in the areas of financial reporting and management, risk management, loan servicing and securities compliance, and finance transformation. Read more. |
 |
Bill Hederman is a director in Deloitte & Touche LLP’s Enterprise Risk Service practice focusing on energy regulatory compliance. He has more than 25 years of energy industry experience. He served as the founding Director of the FERC’s Office of Market Oversight and Investigations, where he won the agency’s top award for helping address the crisis of confidence that affected energy markets. Read more. |
 |
Elizabeth Krentzman Elizabeth Krentzman serves as the chief advisor to the Investment Management sector of Deloitte & Touche LLP's Governance, Regulatory & Risk Strategies group. She helps lead a seasoned consulting team who assist investment advisers, mutual funds, alternative investment firms, service providers and financial intermediaries in developing and deploying integrated programs for measuring, controlling and monitoring compliance risks and in meeting operational needs. Read more. |
 |
Larry Spears, a director with Deloitte & Touche LLP in the Life Sciences Regulatory and Compliance practice, has more than 30 years of experience with the Food and Drug Administration (FDA) as an investigator, compliance officer, and compliance manager. Read more. Read more. |
As used on this page, “Deloitte” means Deloitte & Touche LLP, a subsidiary of Deloitte LLP, Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.
